Challenges and opportunities associated with rare-variant pharmacogenomics

Area of Science:

• Genomics
• Pharmacogenetics
• Bioinformatics

Background:

• Next-generation sequencing (NGS) has identified numerous rare pharmacogenetic variations.
• The functional impact of these variations on drug response and toxicity is often unknown.
• Interpreting these variations for individual patient care remains a significant challenge.

Purpose of the Study:

• To discuss emerging strategies for interpreting rare pharmacogenetic variations.
• To highlight the synergy between advanced technologies and population-scale data.
• To facilitate individualized clinical decision-making and personalized medicine.

Main Methods:

• Utilizing massively parallel experimental assays.
• Applying artificial intelligence (AI) and machine learning algorithms.
• Integrating data from population-scale biobank projects.

Main Results:

• Emerging strategies show promise in bridging the translational gap for pharmacogenetic data.
• AI and machine learning can effectively analyze large-scale genomic datasets.
• Synergistic approaches facilitate the interpretation of NGS data for clinical application.

Conclusions:

• Interpreting rare pharmacogenetic variations is crucial for personalized medicine.
• Advanced computational methods and biobanks are key to unlocking the clinical utility of NGS data.
• These integrated strategies will enable more precise and individualized patient care.